Suggested remit - To appraise the clinical and cost effectiveness of atezolizumab within its marketing authorisation for untreated non-squamous non-small-cell lung cancer
 
Status In progress
Process STA 2018
ID number 1495

Provisional Schedule

Expected publication 14 October 2020

Project Team

Project lead Emily Richards

Email enquiries

Timeline

Key events during the development of the guidance:

Date Update
18 July 2019 - 15 August 2019 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
07 June 2019 As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer. Following on from information received from the company, please note that the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid- November 2019.
11 January 2019 As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer. Following on from information received from the company, please note that the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in late September 2019.
02 October 2018 - 30 October 2018 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators
22 October 2018 On receiving updated regulatory timing information from the company that markets the technology, NICE has agreed that scoping the topic at this time would not be appropriate. Consequently the consultation on the draft scope will not continue. The consultation will be rescheduled to take place in line with anticipated regulatory approval timings. We apologise for any inconvenience this may cause. If you have any comments or concerns please contact the project manager for this proposed appraisal Emily Richards on (44 (0)161 413 4070 or via email on emily.richards@nice.org.uk
24 April 2018 In progress, Topic referred

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance